The names on this page are hidden. Create a free account to reveal 5 records a month, or get Venture Capital Intelligence at $199 a month for every name. Every figure, date and source on this page is public either way.

Companies / K••• B••• I•••

K••• B••• I•••

Stage unknownArlington, MAPharmaceuticals
Facts
Year of incorporation
unknown
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
4
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
0
Financing history
4 rounds
  1. Mar 3, 2026
    Form D equity offering · $1.8M (form d sold) · 1 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “••• Locked
  2. Jan 30, 2026
    Form D equity offering · $2.3M (form d sold) · 20 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “••• Locked
  3. Dec 31, 2024
    Form D equity offering · $10.7M (form d sold) · 6 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “••• Locked
  4. Jun 28, 2024
    Form D equity offering · $12.5M (form d sold) · 5 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “••• Locked
Investors on record
0 edges
No named investor yet.
People
7 officers, 11 directors
Timeline
4
  1. Mar 17, 2026
    ••• Locked
  2. Feb 13, 2026
    ••• Locked
  3. Dec 31, 2024
    ••• Locked
  4. Jun 28, 2024
    ••• Locked
Evidence
56 observations
Every observation on this company